{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03849378: Not Applicable Interventional Completed Skin Hypersensitivity
(2019)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04017988: Not Applicable Interventional Unknown status Immunity
(2019)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT01282580: Phase 1 Interventional Completed Breast Cancer
(2010)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02365207: Not Applicable Interventional Terminated Bladder Cancer
(2013)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04360317: Phase 1 Interventional Unknown status Solid Tumor
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02613715: Phase 1 Interventional Completed Overweight and Obesity
(2015)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04482478: Not Applicable Interventional Recruiting Functional Dyspepsia
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
JAN:CATALPA FRUIT [JAN]
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
Expert Rev Gastroenterol Hepatol. Mar 2021;15(3):325-331.: Not Applicable Human clinical trial Completed Gastroenteritis/complications
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT02617264: Not Applicable Interventional Unknown status Breast Cancer
(2016)
Source URL:
Class:
STRUCTURALLY DIVERSE